Epidemiology of birth defects based on a birth defect surveillance system in Southern Jiangsu, China, 2014-2018

Ying Zhou1, Xueqin Mao1, Hua Zhou1

  • 1Changzhou Maternity and Child Health Care Hospital affiliated to Nanjing Medical University, Changzhou, China.

Insights

Birth defects (BDs) prevalence in Changzhou infants increased significantly from 2014-2018, with congenital heart defects and polydactyly on the rise. Male infants had a higher risk of BDs, necessitating improved prevention strategies.

Area of Science:

  • Public Health
  • Epidemiology
  • Perinatal Health

Background:

  • Changzhou experienced a rapid increase in birth defect (BD) prevalence.
  • This trend posed significant challenges for BD prevention efforts in the region.

Purpose of the Study:

  • To describe the epidemiology of BDs in perinatal infants (PIs) in Changzhou from 2014 to 2018.
  • To identify trends and risk factors associated with BDs in this population.

Main Methods:

  • Surveillance data from 56 Changzhou hospitals were analyzed.
  • Poisson regression models were used to assess prevalence rates, trends, and risk factors (year, infant gender, maternal age, season).

Main Results:

  • A total of 1707 BDs were reported among 238,712 PIs (average prevalence: 71.51/10,000).
  • Overall BD prevalence showed a significant uptrend (aPRR=1.133). Polydactyly, congenital heart defects (CHD), and syndactyly increased, while congenital esophageal atresia decreased.
  • Male infants had a higher risk of BDs (aPRR=1.235).

Conclusions:

  • A significant increase in BD prevalence was observed in Changzhou PIs between 2014-2018.
  • Key BDs like CHD, polydactyly, and syndactyly showed increasing trends, while congenital esophageal atresia declined.
  • Male infant gender is a risk factor; enhanced surveillance, public education, and advanced diagnostics are crucial for BD prevention.
Abstract

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
410
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.2K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K